Filing Flows

Filing Flows › Companies › Solesence › Cash flow

Solesence cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow$191K in Q2 2026 · $1.0M over twelve months

Operating cash flow$191K
Free cash flow+$191K
Cash conversion cycle120 days

Analysis

In Q2 2026, Solesence generated $191K of operating cash flow. That is $845K more than in Q2 2025 (−$654K).

Over the twelve months to Jun 30, 2026, operating cash flow was $1.0M; the largest uses were other financing ($2.3M), other investing ($1.9M); besides operations, cash came from shares issued ($100K); the cash balance fell by $3.1M.

Operating cash flow was $191K against net income of −$158K. The largest differences: receivables −$3.0M, inventory +$1.1M, accrued liabilities +$972K.

Its cash conversion cycle was 120 days (receivables 47 + inventory 115 − payables 41).

Free cash flow

Solesence: free cash flow by quarterSolesence: free cash flow by quarter$2.8MQ3 2024−$404KQ4 2024−$7.2MQ1 2025−$654KQ2 2025−$2.5MQ3 2025$1.8MQ4 2025$1.5MQ1 2026$191KQ2 2026
Operating cash flow less capital spending.
Solesence: operating cash flow against capital spendingSolesence: operating cash flow against capital spendingOperating cash flowCapital spending$4.2M$1.4MQ3 2024$2.2M$2.6MQ4 2024−$7.2M$0Q1 2025−$654K$0Q2 2025−$2.5M$0Q3 2025$1.8M$0Q4 2025$1.5M$0Q1 2026$191K$0Q2 2026
Latest (Q2 2026): Operating cash flow $191K, Capital spending $0.

Capital allocation, year by year

Solesence: where the cash came from (up) and went (down), by fiscal yearSolesence: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY2021: Operating cash flow $2.3MFY2021: Net borrowing −$677KFY2021: Shares issued $234KFY2021: Capital spending −$1.9M$2.6MFY2021FY2022: Operating cash flow −$1.6MFY2022: Net borrowing $2.8MFY2022: Shares issued $182KFY2022: Capital spending −$2.8M$3.0MFY2022FY2023: Operating cash flow −$2.0MFY2023: Net borrowing $2.0MFY2023: Shares issued $73KFY2023: Capital spending −$1.1M$2.1MFY2023FY2024: Operating cash flow $2.0MFY2024: Net borrowing −$2.0MFY2024: Shares issued $10.2MFY2024: Capital spending −$4.6M$12.1MFY2024FY2025: Operating cash flow −$8.6MFY2025: Net borrowing $10.3MFY2025: Shares issued $323K$10.6MFY2025
Over these 5 years operating cash flow totalled −$7.9M; the largest uses were operating cash flow ($12.2M) and capital spending ($10.3M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$1.0M
Debtnone
Net cash$1.0M

Solesence funds itself: free cash flow was $1.0M over the last twelve months, with $1.0M of cash and investments and no debt on the balance sheet.

Where the cash came from and went

Solesence: sources (+) and uses (−) of cash, Q2 2026Solesence: sources (+) and uses (−) of cash, Q2 2026Other financing$740KCash drawn (+) / kept (−)−$473KOther investing−$469KOperating cash flow$191KShares issued$11K
Solesence: sources (+) and uses (−) of cash, TTM to Q2 2026Solesence: sources (+) and uses (−) of cash, TTM to Q2 2026Cash drawn (+) / kept (−)$3.1MOther financing−$2.3MOther investing−$1.9MOperating cash flow$1.0MShares issued$100K

From profit to cash

Solesence: net income to operating cash flow, Q2 2026Solesence: net income to operating cash flow, Q2 2026Net income−$158KDepreciation & amortization$323KStock-based pay$79KReceivables−$3.0MInventory$1.1MPayables$392KAccrued liabilities$972KDeferred revenue$772KPrepaid and other assets−$20KOperating cash flow$191K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 20264711541120
Q1 20264613240138
Q4 20256117245188
Q3 20256515948176
Q2 20254513653129
Q1 20254316973139
Q4 20245016673142
Q3 20244012452112

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026$191K——$11K−$473K$191K
Q1 2026$1.5M——$16K$715K$1.5M
Q4 2025$1.8M—−$547K$37K−$859K$1.8M
Q3 2025−$2.5M—−$786K$36K$3.7M−$2.5M
Q2 2025−$654K—$4.1M$246K−$2.3M−$654K
Q1 2025−$7.2M—$7.5M$4K−$408K−$7.2M
Q4 2024$2.2M−$2.6M—$176K$1.5M−$404K
Q3 2024$4.2M−$1.4M—$78K−$567K$2.8M

Solesence: income statement and cash flow

Solesence, Q2 2026: revenue $15.3M (-25% year over year), operating margin 0.8%. The chart follows the revenue to costs, profit and cash.

Solesence: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.